What one share of Clinuvel Pharmaceuticals Limited holds
Headquartered in Melbourne, Australia, and with operations in Europe, Singapore, and the U.S., Clinuvel is a global specialty pharmaceutical group focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations.
Clinuvel Pharmaceuticals Limited’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.27 |
|---|---|
| Profit | $0.46 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | $0.23 |
| Dividends | $0.03 |
| Cash and investments | $0.28 |
| Book value | $3.74 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $1.13 | $0.46 | $0.07 | $0.39 | — | $2.71 |
| 2025 | $1.21 | $0.46 | $0.00 | $0.54 | — | $3.13 |
| 2026 | $1.27 | $0.46 | $0.02 | $0.23 | — | $3.74 |
Common questions about Clinuvel Pharmaceuticals Limited
How much does one share of Clinuvel Pharmaceuticals Limited earn?
Over its latest fiscal year, each share of Clinuvel Pharmaceuticals Limited earned $0.46 of profit on $1.27 of sales, keeping about 36¢ of every $1 (profit margin).
Does Clinuvel Pharmaceuticals Limited pay a dividend?
Yes. Clinuvel Pharmaceuticals Limited paid $0.03 per share in dividends over its latest fiscal year. That’s about 7¢ of each $1 of profit (payout ratio).
What is Clinuvel Pharmaceuticals Limited’s book value per share?
Clinuvel Pharmaceuticals Limited’s book value is $3.74 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Clinuvel Pharmaceuticals Limited have?
Each share of Clinuvel Pharmaceuticals Limited has $0.28 of cash and investments, as of June 30, 2026.
What is Clinuvel Pharmaceuticals Limited’s free cash flow per share?
$0.23 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the Relevant Investor glossary.